>

Jeffrey Needham - Perrigo Company President

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>PRG</div>
PRGO -- USA Stock  

0.225 Dividend

  President
Mr. Jeffrey R. Needham serves as Executive Vice President, President Consumer Healthcare Americas of the Company. He served as Senior Vice President of Commercial Business Development for Consumer Healthcare from March 2005 through October 2009. Previously, he served as Senior Vice President of International from November 2004 to March 2005. He served as Managing Director of Perrigos U.K. operations from May 2002 to November 2004 and as Vice President of Marketing from 1993 to 2002.
Age: 61  President Since 2009      
353 1 709 4000  http://www.perrigo.com

Jeffrey Needham Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Heidi ChenZoetis
2012
Sandra BeatyZoetis
2012
Peter PowchikRegeneron Pharmaceuticals
2006
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Ganadhish KamatDr Reddys Laboratories Ltd
2016
Daniel PlewRegeneron Pharmaceuticals
2016
Amit SachdevVertex Pharmaceuticals Incorpor
2017
John GrayVertex Pharmaceuticals Incorpor
2019
K RaoDr Reddys Laboratories Ltd
2016
Samiran DasDr Reddys Laboratories Ltd
2016
Marion McCourtRegeneron Pharmaceuticals
2018
Alok SonigDr Reddys Laboratories Ltd
2015
Christopher FenimoreRegeneron Pharmaceuticals
2017
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Roxanne LaganoZoetis
2015
Roman TrawickiZoetis
2015
Joseph LaRosaRegeneron Pharmaceuticals
2019
George YancopoulosRegeneron Pharmaceuticals
2016
Catherine KnuppZoetis
2012

Company Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, PresidentView
Gary Cohen, Independent DirectorView
Arthur Shannon, IR Contact OfficerView
Ronald Winowiecki, Acting CFOView
Svend Andersen, Executive Vice President and President - Consumer Healthcare InternationalView
Judy Brown, CFO and Executive VPView
Laurie Brlas, Independent DirectorView
Donal OConnor, Independent DirectorView
James Michaud, Chief Human Resource Officer, Executive Vice PresidentView
Louis Yu, Executive Vice President - Global QualityView
John Wesolowski, Executive Vice President and Presidentident - RXView
Theodore Samuelsto, Independent DirectorView
Scott Jamison, Executive Vice President General Manager - NutritionalsView
Ellen Hoffing, Independent DirectorView
Marc Coucke, Executive Vice President General Manager - Omega Pharma BusinessView
Adriana Karaboutis, Independent DirectorView
Michael Jandernoa, Independent DirectorView
Paul Weninger, Executive Vice President - Global Quality OperationsView
Thomas Farrington, Senior Vice President CIOView
Herman Morris, Independent DirectorView
Jeffrey Needham, Executive Vice President General Manager - Consumer HealthcareView
Todd Kingma, Executive VP, General Counsel and SecretaryView
Rolf Classon, Independent DirectorView
Raymond Silcock, CFOView
Shlomo Yanai, Independent Director NomineeView
Jatin Shah, Senior Vice President Chief Scientific OfficerView
Michael Stewart, Senior Vice President - Global Human ResourcesView
Jeffrey Kindler, Independent DirectorView
Jacqualyn Fouse, Independent DirectorView
Grainne Quinn, Executive Vice President Chief Medical OfficerView
Theodore Samuels, Independent DirectorView
Geoffrey Parker, Independent DirectorView
Murray Kessler, President CEO, DirectorView
Sharon Kochan, Executive VP and General Manager of InternationalView
Gary Kunkle, Lead Independent DirectorView
Joseph Papa, Chairman and CEOView
Marry Brlas, Independent Chairman of the BoardView
Bradley Alford, Independent DirectorView
Jeffrey Smith, Independent DirectorView
Bradley Joseph, IR Contact OfficerView
James Dillard, Executive Vice President Chief Scientific OfficerView
Douglas Boothe, Executive Vice President General Manager - Rx PharmaceuticalsView
Ronald Janish, Executive Vice President - Global Operations and Supply ChainView
Uwe Rohrhoff, President CEO, DirectorView

Stock Performance Indicators

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Currently Active Assets on Macroaxis

GM   
Purchased over 100 shares of
a day ago
Traded for 30.71
ECA   
Purchased over 500 shares of
a day ago
Traded for 3.54
GM   
Purchased over 100 shares of
a day ago
Traded for 30.71
WD   
Purchased over 40 shares of
a day ago
Traded for 66.38
DD   
Purchased over 70 shares of
a day ago
Traded for 43.18
Please check Your Equity Center. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.